Jo-Fen Liu1, Robert A Dineen1,2,3, Shivaram Avula4, Tom Chambers1,3, Manali Dutta1, Tim Jaspan1,3, Donald C MacArthur1,5, Simon Howarth1,5, Daniele Soria6, Philip Quinlan7,8, Srikrishna Harave4, Chan Chang Ong4, Conor L Mallucci9, Ram Kumar10, Barry Pizer11, David A Walker2. 1. a Children's Brain Tumour Research Centre , University of Nottingham , Nottingham , UK. 2. b Radiological Sciences, Division of Clinical Neuroscience , University of Nottingham , Nottingham , UK. 3. c Department of Radiology , Nottingham University Hospitals NHS Trust , Nottingham , UK. 4. d Department of Radiology , Alder Hey Children's NHS Foundation Trust , Liverpool , UK. 5. e Department of Neurosurgery , Nottingham University Hospitals NHS Trust , Nottingham , UK. 6. f Department of Computer Science , University of Westminster , London , UK. 7. g Advanced Data Analysis Centre , University of Nottingham , Nottingham , UK. 8. h School of Computer Sciences , University of Nottingham , Nottingham , UK. 9. i Department of Neurosurgery , Alder Hey Children's NHS Foundation Trust , Liverpool , UK. 10. j Department of Neurology , Alder Hey Children's NHS Foundation Trust , Liverpool , UK. 11. k Department of Oncology , Alder Hey Children's NHS Foundation Trust , Liverpool , UK.
Abstract
BACKGROUND: Despite previous identification of pre-operative clinical and radiological predictors of post-operative paediatric cerebellar mutism syndrome (CMS), a unifying pre-operative risk stratification model for use during surgical consent is currently lacking. The aim of the project is to develop a simple imaging-based pre-operative risk scoring scheme to stratify patients in terms of post-operative CMS risk. METHODS: Pre-operative radiological features were recorded for a retrospectively assembled cohort of 89 posterior fossa tumour patients from two major UK treatment centers (age 2-23yrs; gender 28 M, 61 F; diagnosis: 38 pilocytic astrocytoma, 32 medulloblastoma, 12 ependymoma, 1 high grade glioma, 1 pilomyxoid astrocytoma, 1 atypical teratoid rhabdoid tumour, 1 hemangioma, 1 neurilemmoma, 2 oligodendroglioma). Twenty-six (29%) developed post-operative CMS. Based upon results from univariate analysis and C4.5 decision tree, stepwise logistic regression was used to develop the optimal model and generate risk scores. RESULTS: Univariate analysis identified five significant risk factors and C4.5 decision tree analysis identified six predictors. Variables included in the final model are MRI primary location, bilateral middle cerebellar peduncle involvement (invasion and/or compression), dentate nucleus invasion and age at imaging >12.4 years. This model has an accuracy of 88.8% (79/89). Using risk score cut-off of 203 and 238, respectively, allowed discrimination into low (38/89, predicted CMS probability <3%), intermediate (17/89, predicted CMS probability 3-52%) and high-risk (34/89, predicted CMS probability ≥52%). CONCLUSIONS: A risk stratification model for post-operative paediatric CMS could flag patients at increased or reduced risk pre-operatively which may influence strategies for surgical treatment of cerebellar tumours. Following future testing and prospective validation, this risk scoring scheme will be proposed for use during the surgical consenting process.
BACKGROUND: Despite previous identification of pre-operative clinical and radiological predictors of post-operative paediatric cerebellar mutism syndrome (CMS), a unifying pre-operative risk stratification model for use during surgical consent is currently lacking. The aim of the project is to develop a simple imaging-based pre-operative risk scoring scheme to stratify patients in terms of post-operative CMS risk. METHODS: Pre-operative radiological features were recorded for a retrospectively assembled cohort of 89 posterior fossa tumourpatients from two major UK treatment centers (age 2-23yrs; gender 28 M, 61 F; diagnosis: 38 pilocytic astrocytoma, 32 medulloblastoma, 12 ependymoma, 1 high grade glioma, 1 pilomyxoid astrocytoma, 1 atypical teratoid rhabdoid tumour, 1 hemangioma, 1 neurilemmoma, 2 oligodendroglioma). Twenty-six (29%) developed post-operative CMS. Based upon results from univariate analysis and C4.5 decision tree, stepwise logistic regression was used to develop the optimal model and generate risk scores. RESULTS: Univariate analysis identified five significant risk factors and C4.5 decision tree analysis identified six predictors. Variables included in the final model are MRI primary location, bilateral middle cerebellar peduncle involvement (invasion and/or compression), dentate nucleus invasion and age at imaging >12.4 years. This model has an accuracy of 88.8% (79/89). Using risk score cut-off of 203 and 238, respectively, allowed discrimination into low (38/89, predicted CMS probability <3%), intermediate (17/89, predicted CMS probability 3-52%) and high-risk (34/89, predicted CMS probability ≥52%). CONCLUSIONS: A risk stratification model for post-operative paediatric CMS could flag patients at increased or reduced risk pre-operatively which may influence strategies for surgical treatment of cerebellar tumours. Following future testing and prospective validation, this risk scoring scheme will be proposed for use during the surgical consenting process.
Authors: Camilla de Laurentis; Paola M F Cristaldi; Paola Rebora; Maria Grazia Valsecchi; Veronica Biassoni; Elisabetta Schiavello; Giorgio G Carrabba; Andrea Trezza; Francesco DiMeco; Paolo Ferroli; Giuseppe Cinalli; Marco Locatelli; Marco Cenzato; Giuseppe Talamonti; Marco M Fontanella; Giannatonio Spena; Roberto Stefini; Claudio Bernucci; Silvio Bellocchi; Davide Locatelli; Maura Massimino; Carlo Giussani Journal: J Neurooncol Date: 2022-06-29 Impact factor: 4.506
Authors: Rashad Jabarkheel; Nisreen Amayiri; Derek Yecies; Yuhao Huang; Sebastian Toescu; Liana Nobre; Donald J Mabbott; Sniya V Sudhakar; Prateek Malik; Suzanne Laughlin; Maisa Swaidan; Maysa Al Hussaini; Awni Musharbash; Geeta Chacko; Leni G Mathew; Paul G Fisher; Darren Hargrave; Ute Bartels; Uri Tabori; Stefan M Pfister; Kristian Aquilina; Michael D Taylor; Gerald A Grant; Eric Bouffet; Kshitij Mankad; Kristen W Yeom; Vijay Ramaswamy Journal: Neuro Oncol Date: 2020-02-20 Impact factor: 12.300
Authors: Philippe F Paquier; Karin S Walsh; Kimberley M Docking; Helen Hartley; Ram Kumar; Coriene E Catsman-Berrevoets Journal: Childs Nerv Syst Date: 2019-06-20 Impact factor: 1.475
Authors: Sebastian M Toescu; Samantha Hettige; Kim Phipps; R J Paul Smith; Verity Haffenden; Chris Clark; Richard Hayward; Kshitij Mankad; Kristian Aquilina Journal: Childs Nerv Syst Date: 2018-06-20 Impact factor: 1.475
Authors: Frederik Grosse; Stefan Mark Rueckriegel; Ulrich-Wilhelm Thomale; Pablo Hernáiz Driever Journal: Childs Nerv Syst Date: 2021-08-05 Impact factor: 1.475